ÖZCAN, M. Et Al. 2015. Azacitidine in combination with ATRA, valproic acid in elderly AML patients.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , (Illinois, United States Of America).

ÖZCAN, M., CİVRİZ BOZDAĞ, S., Atesagaoglu, B., Atilla, E., Ataca, P., TOPRAK, S. K., ... YÜKSEL, M.(2015). Azacitidine in combination with ATRA, valproic acid in elderly AML patients. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America

ÖZCAN, MUHİT Et Al. "Azacitidine in combination with ATRA, valproic acid in elderly AML patients.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 2015

ÖZCAN, MUHİT Et Al. "Azacitidine in combination with ATRA, valproic acid in elderly AML patients.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America, 2015

ÖZCAN, M. Et Al. (2015) . "Azacitidine in combination with ATRA, valproic acid in elderly AML patients.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={MUHİT ÖZCAN Et Al. }, title={Azacitidine in combination with ATRA, valproic acid in elderly AML patients.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer}, city={Illinois}, country={United States Of America}, year={2015}}